Colorectal Cancer section

Colorectal Cancer News & Features

FDA Grants Approval to Bevacizumab-awwb as First Biosimilar for Anticancer Therapy

FDA Grants Approval to Bevacizumab-awwb as First Biosimilar for Anticancer Therapy

Bevacizumab-awwb is a recombinant IgG1 monoclonal antibody that works by binding to vascular endothelial growth factor (VEGF) and inhibits angiogenesis.

Sarcopenia Affects Dose in Reinduction Therapy for Metastatic Colorectal Cancer

Sarcopenia Affects Dose in Reinduction Therapy for Metastatic Colorectal Cancer

Sarcopenia is significantly associated with dose reductions but not with dose-limiting toxicities at initiation of CAPOX-B reinduction therapy in patients with mCRC, researchers reported at ESMO 2017 Congress.

Educational Program Explains Biomarker Testing for Colorectal Cancer

Educational Program Explains Biomarker Testing for Colorectal Cancer

A newly developed patient education resource helps nurses educate patients with colorectal cancer about biomarker testing and counsel them on the significance of the results.

Colorectal Cancer Recurrence Lower in Survivors Who Exercise

Colorectal Cancer Recurrence Lower in Survivors Who Exercise

Researchers examined the impact of exercise and low body fat mass on recurrence of colorectal polyps among survivors of colorectal cancer.

Colorectal Cancer Mortality Rates Down in African Americans

Colorectal Cancer Mortality Rates Down in African Americans

Among adults aged 20 to 54 years, increase in CRC mortality only seen in whites aged 30 to 54 years.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs